361 related articles for article (PubMed ID: 22841285)
21. Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries.
Waksman R; Pakala R; Baffour R; Hellinga D; Seabron R; Kolodgie F; Virmani R
Cardiovasc Revasc Med; 2006; 7(3):179-84. PubMed ID: 16945826
[TBL] [Abstract][Full Text] [Related]
22. Experimental efficacy of an everolimus eluting cobalt chromium stent.
Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
[TBL] [Abstract][Full Text] [Related]
23. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
24. Comparison of vasa vasorum after intravascular stent placement with sirolimis drug-eluting and bare metal stents.
Sahler LG; Davis D; Saad WE; Patel NC; Lee DE; Waldman DL
J Med Imaging Radiat Oncol; 2008 Dec; 52(6):570-5. PubMed ID: 19178631
[TBL] [Abstract][Full Text] [Related]
25. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of novel biolimus eluting DEVAX AXXESS plus nitinol self-expanding stent in a porcine coronary model.
Cilingiroglu M; Elliott J; Patel D; Tio F; Matthews H; McCasland M; Trauthen B; Elicker J; Bailey SR
Catheter Cardiovasc Interv; 2006 Aug; 68(2):271-9. PubMed ID: 16810698
[TBL] [Abstract][Full Text] [Related]
27. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model].
Qiu H; Gao RL; Tang ZR; Meng L; Zhao H; Ruan YM; Zhao H; Yang YJ; Chen JL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):561-4. PubMed ID: 16053797
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in neointimal hyperplasia following endeavor zotarolimus-eluting stent implantation.
Nakatani D; Ako J; Tremmel JA; Waseda K; Otake H; Koo BK; Miyazawa A; Hongo Y; Hur SH; Sakurai R; Yock PG; Honda Y; Fitzgerald PJ
Am J Cardiol; 2011 Oct; 108(7):912-7. PubMed ID: 21784390
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
31. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
32. In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents.
Wakabayashi K; Mintz G; Delhaye C; Choi YJ; Doh JH; Ben-Dor I; Gaglia M; Pakala R; Suddath W; Satler L; Kent K; Pichard A; Weissman N; Waksman R
J Invasive Cardiol; 2011 Jul; 23(7):262-8. PubMed ID: 21725119
[TBL] [Abstract][Full Text] [Related]
33. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
[TBL] [Abstract][Full Text] [Related]
34. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.
Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M
EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128
[TBL] [Abstract][Full Text] [Related]
35. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
[TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
37. Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.
Tellez A; Afari ME; Buszman PP; Seifert P; Cheng Y; Milewski K; McGregor JC; Garza JA; Roberts MB; Yi GH; Kaluza GL; Granada JF
Coron Artery Dis; 2014 Nov; 25(7):595-601. PubMed ID: 25013949
[TBL] [Abstract][Full Text] [Related]
38. Oral everolimus inhibits in-stent neointimal growth.
Farb A; John M; Acampado E; Kolodgie FD; Prescott MF; Virmani R
Circulation; 2002 Oct; 106(18):2379-84. PubMed ID: 12403670
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
40. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
